{"operation":"document","citation":"PI-94-002","title":"Pipeline Safety Interpretation PI-94-002","source_type":"guidance","agency":"Pipeline and Hazardous Materials Safety Administration","status":"guidance","official":true,"published_on":"1994-01-11","effective_on":null,"summary":"PI-94-002 concerning 199.3.","machine_formats":{"json":"https://regulus.evalyn.ai/document/phmsa-interpretation-pi-94-002.json","markdown":"https://regulus.evalyn.ai/document/phmsa-interpretation-pi-94-002.md"},"app_url":"https://regulus.evalyn.ai/document/phmsa-interpretation-pi-94-002","source_url":"https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/docs/standards-rulemaking/pipeline/interpretations/76341/pi-94002.pdf","body":"<<<PAGE 1>>>\n\nJanuary 11, 1994\nThis is in response to your correspondence of September 17, 1993, requesting an opinion to\ndetermine whether services provided by a particular contractor would subject their employees to\nthe drug testing requirements under Parts 199 and 40.\nYour correspondence indicates that the contractor shall perform such functions as ultrasonic\ntesting techniques, radiographic test methods to include isotope or x-ray, liquid penetrate\nexaminations, and magnetic particle testing methods. Based on the information you provided, it\nwould appear that the contractor's employees would perform covered functions on a pipeline or\nLNG facility that would subject them to the drug testing regulations.\nThank you for your inquiry. Please let me know if you need additional information about our\ndrug testing requirements.\nSincerely,\nRichard L. Rippert\nDrug Compliance Coordinator\nOffice of Pipeline Safety\nCompliance\ndal\n94-01-11","truncated":false,"body_characters":942}